Market Place
Sourcing Support
Sandoz And Liquidia Win $137M Against United In Remodulin Dispute
16 Sep 2024 //
FIERCE PHARMA
Liquidia challenges regulatory exclusivity for rival`s inhaled drug
23 Aug 2024 //
REUTERS
Liquidia Full Approval for Pulmonary Hypertension Drug as Competitor Retains Market Exclusivity
20 Aug 2024 //
BIOSPACE
FDA Balks At Standard Approval For Liquidia`s PAH Rival To United`s Tyvaso
19 Aug 2024 //
FIERCE PHARMA
Liquidia to Present at 23rd Needham Healthcare Conference
02 Apr 2024 //
PRESS RELEASE
Courts clear FDA to approve Liquidia`s PAH drug Yutrepia
02 Apr 2024 //
FIERCE PHARMA
United Therapeutics starts litigation with FDA over rival Liquidia`s drug application
22 Feb 2024 //
REUTERS
Liquidia and United Therapeutics could bring new lung indication into legal saga
29 Jun 2023 //
ENDPTS
Liquidia Reports Full Year 2022 Financial Results and Provides Corporate Update
16 Mar 2023 //
PRESS RELEASE
Liquidia to Report Full Year 2022 Financial Results on Thursday, March 16, 2023
09 Mar 2023 //
PRESS RELEASE
Liquidia Announces Collaboration to Develop a New Infusion Pump of Treprostinil
05 Dec 2022 //
GLOBENEWSWIRE
Liquidia Provides Update on Hatch-Waxman Litigation and to Host Call on September 1, 2022, at 8:00am E.T.
31 Aug 2022 //
PRESS RELEASE
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
22 Aug 2022 //
PRESS RELEASE
Liquidia Reports Q2 2022 Financial Results and Provides Corporate Update
11 Aug 2022 //
PRESS RELEASE
Liquidia to Report Second Quarter 2022 Financial Results on August 11, 2022
04 Aug 2022 //
PRESS RELEASE
Liquidia to Participate in Upcoming Investor Conferences
01 Aug 2022 //
PRESS RELEASE
Liquidia to Publish Long-Term Clinical Data from Completed INSPIRE Study
01 Aug 2022 //
PRESS RELEASE
Liquidia Receive Favorable Ruling in Inter Partes Review against United`s Patent
19 Jul 2022 //
LIQUIDIA
Liquidia Corp Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
25 Apr 2022 //
PRESS RELEASE
Liquidia Announces Oral Presentation at the 42nd ISHLT
20 Apr 2022 //
PRESS RELEASE
Liquidia Closes Public Offering of Common Stock
18 Apr 2022 //
PRESS RELEASE
Liquidia Announces Pricing of Public Offering of Common Stock
12 Apr 2022 //
PRESS RELEASE
Liquidia Announces Generic Treprostinil Injection Will Be Available
30 Mar 2021 //
BENZINGA
Liquidia Announces Notice of Allowance for US Patent Application Methods
28 Aug 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.